Notice of Intent To Grant Exclusive Patent License; Seahawk Biosystems Corporation, 65092 [E6-18769]

Download as PDF 65092 Federal Register / Vol. 71, No. 215 / Tuesday, November 7, 2006 / Notices physical equipment, fiscal affairs, academic methods, and other matters relating to the Academy. A portion of the meeting will be open to the public while the other will be closed to the public to discuss matters listed in Paragraphs (2) and (6) of Subsection (c) of Section 552b, Title 5, United States Code. The determination to close one session is based on the consideration that portions of the briefings and discussion will relate to information of a personal nature that, if disclosed, would constitute a clearly unwarranted invasion of personal privacy. The balance of the closed session will address the internal policies and administrative practices of the Board of Visitors of the Academy. Meeting sessions will be held in the House Armed Services Committee Conference Room in the Rayburn Building in Washington, DC. A delay in publishing this notification within fifteen, calendar days resulted from the need to ensure proper administrative coordination and approval to close a portion of the meeting. FOR FURTHER INFORMATION CONTACT: Or to attend the 15 & 16 November Board of Visitors meeting, contact Captain Brad Head, Chief, USAFA Programs Assessment, Directorate of Airman Development, Deputy Chief of Staff, Manpower & Personnel, AF/A1DOA, 1040 Air Force Pentagon, Washington, DC, 20330–1040, (703) 697–8650. Contact Ms. Beverly Houtz, Academic Affairs Office, Air Force Institute of Technology, (937) 255–6565 ext 4424. Bao-Anh Trinh, Air Force Federal Register Liaison Officer. [FR Doc. E6–18738 Filed 11–6–06; 8:45 am] dust, powder, solid waste, etc.), gases (e.g. air, etc.), and liquids; and pathogen and toxin detection, and disease and infection diagnostic testing in solid, liquid, and gaseous material, animals and humans as performed by first responders, field operatives, laboratories, clinics, or other similar confidential and non-confidential uses by private industry or government for biodefense (measures against attacks using biological agents or for the prevention or monitoring thereof), antibioterrorism (measures for the prevention or monitoring of real, potential, or perceived terrorist acts involving the use of real, potential, or perceived biological warfare agents such as disease-causing viruses, bacteria, or toxins), national security (measures for the defense of a country and the protection of the interests/assets of a country from biological threats), or intelligence (measures for the collection of information directly or indirectly about a threat or potential threat from an enemy or potential enemy that may pose real, potential, or perceived biological warfare risks to a country or its assets) applications in the United States and certain foreign countries, the Government-owned inventions described in U.S. Patent Application Serial No. 10/457,705: Force Discrimination Assay, Navy Case No. 84,529.//U.S. Patent Application Serial No. 11/424,643: Method for Modifying Nitride Substrates for Covalent Immobilization of Aminated Molecules, Navy Case No. 97,198 and any continuations, divisionals, or re-issues thereof. BILLING CODE 5001–05–P Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than November 22, 2006. DATES: DEPARTMENT OF DEFENSE Department of the Navy Notice of Intent To Grant Exclusive Patent License; Seahawk Biosystems Corporation Department of the Navy, DoD. Notice. AGENCY: ycherry on PROD1PC64 with NOTICES ACTION: SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to Seahawk Biosystems Corporation, a revocable, non-assignable, exclusive license to practice in the fields of pathogen and toxin detection, and genetic testing in food products derived from vegetables and other organic and non-organic food stuff; pathogen and toxin detection in, and monitoring of, environmental and waste samples such as solid/particulate matter (e.g. soil, dirt, VerDate Aug<31>2005 14:44 Nov 06, 2006 Jkt 211001 Written objections are to be filed with the Naval Research Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375– 5320. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Head, Technology Transfer Office, NRL Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375–5320, telephone 202–767–7230. Due to U.S. Postal delays, please fax 202–404–7920, email: techtran@utopia.nrl.navy.mil or use courier delivery to expedite response. (Authority: 35 U.S.C. 207, 37 CFR part 404.) PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 Dated: October 31, 2006. M.A. Harvison, Lieutenant Commander, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. E6–18769 Filed 11–6–06; 8:45 am] BILLING CODE 3810–FF–P DEPARTMENT OF ENERGY International Energy Agency Meeting Department of Energy. Notice of meetings. AGENCY: ACTION: SUMMARY: The Industry Advisory Board (IAB) to the International Energy Agency (IEA) will meet on November 14–16, 2006, at the headquarters of the IEA in Paris, France, including in connection with a joint meeting of the IEA’s Standing Group on Emergency Questions (SEQ) and the IEA’s Standing Group on the Oil Market on November 14 and 15, and a meeting of the SEQ on November 16. DATES: November 14–16, 2006. ´ ´ ADDRESSES: 9, rue de la Federation, Paris, France. FOR FURTHER INFORMATION CONTACT: Samuel M. Bradley, Assistant General for International and National Security Programs, Department of Energy, 1000 Independence Avenue, SW., Washington, DC 20585, 202–586–6738. SUPPLEMENTARY INFORMATION: In accordance with section 252(c)(1)(A)(i) of the Energy Policy and Conservation Act (42 U.S.C. 6272(c)(1)(A)(i)) (EPCA), the following notice of meeting is provided: Meetings of the Industry Advisory Board (IAB) to the International Energy Agency (IEA) will be held at the headquarters of the IEA, 9, rue de la ´ ´ Federation, Paris, France, on November 14, 2006, beginning at 10:45 a.m. and continuing on November 15, 2006 at 9 a.m.; at 3 p.m. on November 15, and on November 16, 2006, commencing at 9 a.m. The purpose of this notice is to permit attendance by representatives of U.S. company members of the IAB at a joint meeting of the IEA’s Standing Group on Emergency Questions (SEQ) and the IEA’s Standing Group on the Oil Market (SOM) on November 14 and 15, at a meeting of the IAB on November 15, and at a meeting of the SEQ on November 16. The agenda of the joint SEQ/SOM meeting on November 14 and 15 is under the control of the SEQ and the SOM. It is expected that the SEQ and the SOM will adopt the following agenda: 1. Review provisional agenda of the joint SEQ/SOM session. E:\FR\FM\07NON1.SGM 07NON1

Agencies

[Federal Register Volume 71, Number 215 (Tuesday, November 7, 2006)]
[Notices]
[Page 65092]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-18769]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent To Grant Exclusive Patent License; Seahawk 
Biosystems Corporation

AGENCY: Department of the Navy, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to Seahawk Biosystems Corporation, a revocable, non-
assignable, exclusive license to practice in the fields of pathogen and 
toxin detection, and genetic testing in food products derived from 
vegetables and other organic and non-organic food stuff; pathogen and 
toxin detection in, and monitoring of, environmental and waste samples 
such as solid/particulate matter (e.g. soil, dirt, dust, powder, solid 
waste, etc.), gases (e.g. air, etc.), and liquids; and pathogen and 
toxin detection, and disease and infection diagnostic testing in solid, 
liquid, and gaseous material, animals and humans as performed by first 
responders, field operatives, laboratories, clinics, or other similar 
confidential and non-confidential uses by private industry or 
government for biodefense (measures against attacks using biological 
agents or for the prevention or monitoring thereof), anti-bioterrorism 
(measures for the prevention or monitoring of real, potential, or 
perceived terrorist acts involving the use of real, potential, or 
perceived biological warfare agents such as disease-causing viruses, 
bacteria, or toxins), national security (measures for the defense of a 
country and the protection of the interests/assets of a country from 
biological threats), or intelligence (measures for the collection of 
information directly or indirectly about a threat or potential threat 
from an enemy or potential enemy that may pose real, potential, or 
perceived biological warfare risks to a country or its assets) 
applications in the United States and certain foreign countries, the 
Government-owned inventions described in U.S. Patent Application Serial 
No. 10/457,705: Force Discrimination Assay, Navy Case No. 84,529.//U.S. 
Patent Application Serial No. 11/424,643: Method for Modifying Nitride 
Substrates for Covalent Immobilization of Aminated Molecules, Navy Case 
No. 97,198 and any continuations, divisionals, or re-issues thereof.

DATES: Anyone wishing to object to the grant of this license must file 
written objections along with supporting evidence, if any, not later 
than November 22, 2006.

ADDRESSES: Written objections are to be filed with the Naval Research 
Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-
5320.

FOR FURTHER INFORMATION CONTACT: Head, Technology Transfer Office, NRL 
Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-5320, 
telephone 202-767-7230. Due to U.S. Postal delays, please fax 202-404-
7920, e-mail: techtran@utopia.nrl.navy.mil or use courier delivery to 
expedite response.

(Authority: 35 U.S.C. 207, 37 CFR part 404.)

    Dated: October 31, 2006.
M.A. Harvison,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Federal Register Liaison Officer.
 [FR Doc. E6-18769 Filed 11-6-06; 8:45 am]
BILLING CODE 3810-FF-P